KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Current Assets (2016 - 2025)

Bausch Health Companies' Current Assets history spans 17 years, with the latest figure at $6.2 billion for Q4 2025.

  • For Q4 2025, Current Assets rose 6.63% year-over-year to $6.2 billion; the TTM value through Dec 2025 reached $6.2 billion, up 6.63%, while the annual FY2025 figure was $6.2 billion, 6.63% up from the prior year.
  • Current Assets for Q4 2025 was $6.2 billion at Bausch Health Companies, down from $6.2 billion in the prior quarter.
  • Across five years, Current Assets topped out at $6.5 billion in Q2 2025 and bottomed at $4.0 billion in Q3 2022.
  • The 5-year median for Current Assets is $5.4 billion (2024), against an average of $5.3 billion.
  • The largest YoY upside for Current Assets was 31.76% in 2023 against a maximum downside of 27.4% in 2023.
  • A 5-year view of Current Assets shows it stood at $5.6 billion in 2021, then decreased by 24.26% to $4.2 billion in 2022, then surged by 31.76% to $5.6 billion in 2023, then grew by 3.18% to $5.8 billion in 2024, then grew by 6.63% to $6.2 billion in 2025.
  • Per Business Quant, the three most recent readings for BHC's Current Assets are $6.2 billion (Q4 2025), $6.2 billion (Q3 2025), and $6.5 billion (Q2 2025).